Gan and Lee Pharmaceuticals.
¥68.91
0
-¥0.48-0.69% 07:00 Today
Statistics
Day High
69.38
Day Low
68.3
52W High
82.25
52W Low
51.51
Volume
3,651,181
Avg. Volume
12,355,640
Mkt Cap
41.16B
P/E Ratio
36.33
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Jun 25
¥1.00
Dec 24
¥0.50
Jun 24
¥0.20
Jun 22
¥0.30
May 21
¥0.40
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
22OctExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0.24
0.36
0.48
0.6
Expected EPS
0.59951607
Actual EPS
N/A
Financials
28.58%Profit Margin
Profitable4BRevenue
1.14BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Show more...
CEO
Wei Chen
Employees
5309
Country
China
ISIN
CNE100003ZH1
Listings
0 Comments
Share your thoughts
FAQ
What is Gan and Lee Pharmaceuticals. stock price today?▼
The current price of 603087.SHG is ¥68.91 CNY — it has decreased by -0.69% in the past 24 hours. Watch Gan and Lee Pharmaceuticals. stock price performance more closely on the chart.
What is Gan and Lee Pharmaceuticals. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Shanghai Stock Exchange exchange Gan and Lee Pharmaceuticals. stocks are traded under the ticker 603087.SHG.
Is Gan and Lee Pharmaceuticals. stock price growing?▼
603087.SHG stock has fallen by -0.99% compared to the previous week, the month change is a -1.12% fall, over the last year Gan and Lee Pharmaceuticals. has showed a -7.25% decrease.
What is Gan and Lee Pharmaceuticals. market cap?▼
Today Gan and Lee Pharmaceuticals. has the market capitalization of 41.16B
When is the next Gan and Lee Pharmaceuticals. earnings date?▼
Gan and Lee Pharmaceuticals. is going to release the next earnings report on October 22, 2026.
What were Gan and Lee Pharmaceuticals. earnings last quarter?▼
603087.SHG earnings for the last quarter are 0.32 CNY per share, whereas the estimation was 0.56 CNY resulting in a -43.86% surprise. The estimated earnings for the next quarter are N/A CNY per share.
What is Gan and Lee Pharmaceuticals. revenue for the last year?▼
Gan and Lee Pharmaceuticals. revenue for the last year amounts to 4B CNY.
What is Gan and Lee Pharmaceuticals. net income for the last year?▼
603087.SHG net income for the last year is 1.14B CNY.
Does Gan and Lee Pharmaceuticals. pay dividends?▼
Yes, 603087.SHG dividends are paid quarterly. The last dividend per share was 1 CNY. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Gan and Lee Pharmaceuticals. have?▼
As of September 09, 2026, the company has 5,309 employees.
In which sector is Gan and Lee Pharmaceuticals. located?▼
Gan and Lee Pharmaceuticals. operates in the Health & Wellness sector.
When did Gan and Lee Pharmaceuticals. complete a stock split?▼
The last stock split for Gan and Lee Pharmaceuticals. was on August 20, 2020 with a ratio of 1.4:1.
Where is Gan and Lee Pharmaceuticals. headquartered?▼
Gan and Lee Pharmaceuticals. is headquartered in Beijing, China.